A new consensus from the National Psoriasis Foundation outlines a clear benchmark for remission to improve treatment decisions and patient outcomes.

New psoriasis drug Zoryve approved. How to use & why Black American participation in clinical trials is vital for health equity.

Although some people with plaque psoriasis can control ... Other races included in the study were American Indian or Alaska Native (<2%), Asian (3.5%), Black or African American (3% to 6% ...

The current estimated prevalence of psoriasis is 1.5% in African Americans and 3.6% in Caucasians. 3 “Adolescents living with moderate to severe plaque psoriasis shouldn’t have to wait for effective ...

Had to have a diagnosis of plaque psoriasis for at least 6 months ... patients -- about 86% -- with a little bit of Asian and African American. In terms of overall weight, we know that our ...

Since elementary school, Alisha has struggled with severe plaque psoriasis—a condition which causes raised, inflamed, scaly plaques that may be itchy or painful. When Alisha was young ...

When I was seven years old, I started to get itchy, flaky, inflamed skin across 90% of my body. There was no hiding it. I was diagnosed with psoriatic arthritis. Psoriasis is a chronic autoimmune ...

campaign to raise awareness of plaque psoriasis and the treatments that are available for it. Around 2 million Americans are currently living with moderate to severe plaque psoriasis.

About 80 to 90 percent of people with psoriasis have plaque psoriasis, which often appears as raised, red and scaly plaques. However, in people with darker skin tones, plaques sometimes may appear ...

ORLANDO — Adults and adolescents treated with icotrokinra experienced improvements in their moderate to severe plaque psoriasis, according to a late-breaking presentation at the American Academy ...

San Francisco startup Alumis Inc. has raised $259 million in a bid to best big pharma’s work in plaque psoriasis. Alumis announced its Series C round Wednesday and plans to move its lead drug ...